ARCUTIS BIOTHERAPEUTICS INC (ARQT)
US03969K1088 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 88.40M | 53.60M | 96.40M | 65.10M | 63.30M | |||
| Marketable Securities | 183.46M | 355.90M | 290.60M | 219.40M | 37.90M | |||
| Receivables | 25.81M | 8.50M | 400.00K | 500.00K | N/A | |||
| Inventories | 13.13M | 7.50M | N/A | N/A | N/A | |||
| Other Current Assets | 19.63M | 11.80M | 15.30M | 7.80M | 5.20M | |||
| Total Current Assets | 330.43M | 437.40M | 402.80M | 292.80M | 106.50M | |||
| Non-Current Assets | ||||||||
| PPE Net | 3.90M | 4.60M | 5.30M | 5.40M | 500.00K | |||
| Intangibles | 6.44M | 7.20M | N/A | N/A | N/A | |||
| Other Non-Current Assets | 596.00K | 100.00K | 100.00K | 100.00K | 0.00 | |||
| Total Non-Current Assets | 10.93M | 11.90M | 5.40M | 5.50M | 500.00K | |||
| TOTAL ASSETS | 341.37M | 449.30M | 408.20M | 298.30M | 107.00M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 34.68M | 29.00M | 26.00M | 15.30M | 3.60M | |||
| Accounts Payable | 11.99M | 8.80M | 7.40M | 7.10M | 1.40M | |||
| Other Current Liabilities | N/A | N/A | N/A | 200.00K | 200.00K | |||
| Total Current Liabilities | 46.67M | 37.80M | 33.30M | 22.60M | 5.20M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 201.80M | 197.80M | 72.40M | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 4.23M | 4.10M | 4.80M | 5.00M | 300.00K | |||
| Total Non-Current Liabilities | 206.03M | 201.90M | 77.20M | 5.00M | 400.00K | |||
| TOTAL LIABILITIES | 252.70M | 239.70M | 110.50M | 27.60M | 5.60M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -981.90M | -719.80M | -408.30M | -202.00M | -66.30M | |||
| Additional Paid In Capital | 1.07B | 930.40M | 706.20M | 472.60M | 1.20M | |||
| Common Shares | 9.00K | 0.00 | 0.00 | 0.00 | 166.50M | |||
| Other Shareholders' Equity | 4.00K | -1.10M | -300.00K | 0.00 | 0.00 | |||
| Shares Outstanding | 96.79M | 61.00M | 50.30M | 43.30M | 36.60M | |||
| Tangible Book Value per Share | 0.85 | 3.32 | 5.92 | 6.25 | -1.78 | |||
| Total Shareholders' Equity | 88.67M | 209.60M | 297.70M | 270.60M | 101.50M | |||
| TOTAL LIABILITIES AND EQUITY | 341.37M | 449.30M | 408.20M | 298.30M | 107.00M | |||
| Statistics | ||||||||
| Debt/Equity | 2.28 | 0.94 | 0.24 | N/A | N/A | |||
| Current Ratio | 7.08 | 11.57 | 12.10 | 12.96 | 20.48 | |||
| Return On Assets (ROA) | -76.79% | -69.32% | -50.55% | -45.48% | -39.25% | |||
| Return On Equity (ROE) | -295.65% | -148.60% | -69.32% | -50.14% | -41.38% | |||
All data in USD